Hanall Biopharma Co.,Ltd (009420.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−209.1x

Market Cap

KRW 2.82T

MomentumView details →

1D Return

−2.00%

YTD Return

+25.03%

RSI (14)

46.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−209.1x

Market Cap

KRW 2.82T

RSI (14)

46.6

MomentumView details →

1D Return

−2.00%

YTD Return

+25.03%

ProfitabilityView details →

Gross Margin

52.08%

Net Margin

−15.31%

EBITDA Margin

−8.32%

ROE (TTM)

−15.41%

ROA (TTM)

−10.35%

Asset Turnover

0.67x

GrowthView details →

Revenue YoY

+8.38%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+12.16%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−KRW 368.09

EPS Surprise

−812.52%

Beats (12Q)

0/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

−812.52%

Rev Surprise

12.95%

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

1.49x

Quick Ratio

0.84x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

162.66B

Net Income (TTM)

−24.90B

Op. CF (TTM)

−1.24B

Latest newsMore news →

No recent news for 009420.KS.

Similar companies

Celltrion Pharm, Inc.068760.KQ Yuhan Corporation000105.KS Daewoong pharmaceutical Co.,Ltd069620.KS Yuhan Corporation000100.KS Hanmi Pharm. Co., Ltd.128940.KS JW Pharmaceutical Corporation001067.KS Find similar companies →

Latest newsMore news →

No recent news for 009420.KS.